postmarketing adverse

Related by string. * Postmarketing . Postmarket : conduct postmarketing . During postmarketing surveillance . postmarketing studies . postmarketing surveillance . postmarket studies . postmarket surveillance . postmarket safety / ADVERSE . Adverse : FDA MedWatch Adverse Event . adverse determinations . adverse effects . treatment emergent adverse . adverse impacts . adverse inference * *

Related by context. Frequent words. (Click for all words.) 62 neuropsychiatric symptoms 61 Myfortic 61 vismodegib 61 aseptic meningitis 60 pediatric bipolar disorder 60 heparin induced thrombocytopenia 60 QTc prolongation 60 cardiovascular ischemic 60 efalizumab 60 paliperidone ER 60 neuropsychiatric 59 preclinical efficacy 59 tolerability profiles 59 dyslipidaemia 59 renal toxicity 58 teriflunomide 58 extrapyramidal symptoms 58 ARCOXIA 58 Hematologic 58 Observational studies 58 GSK# [001] 58 teratogenic 57 antiepileptic drug 57 hepatic failure 57 BEXXAR 57 Fibrillex TM 57 receiving VELCADE 57 immunomodulation 57 IBS C 56 MERLIN TIMI 56 rufinamide 56 Vaprisol 56 post herpetic neuralgia PHN 56 etiologic 56 bone marrow suppression 56 neutropenia thrombocytopenia 56 thromboembolic events 56 acute coronary syndromes ACS 56 Kepivance 56 immunodeficiencies 56 PRADAXA 56 hepatotoxicity 56 Natalizumab 56 Canvaxin 56 elotuzumab 56 TYSABRI treated 56 Candesartan 56 angioedema 55 unknown etiology 55 hypersensitivity reactions 55 Focalin XR 55 QT prolongation 55 malignant neoplasms 55 antithrombotic therapy 55 demyelinating disease 55 immunological diseases 55 Tygacil 55 eprotirome 55 pharmacoeconomic 55 telithromycin 55 oxcarbazepine 55 pharmacodynamic effects 55 efficacy tolerability 55 neuroleptic malignant syndrome 55 thromboembolic 55 TRISENOX 55 INTEGRILIN 55 Lactic acidosis 55 vaccinees 55 TYGACIL 55 ximelagatran 55 hypercalcemia 55 retrospective cohort study 55 COPD exacerbations 55 gastrointestinal GI 55 desvenlafaxine 55 fluvastatin 55 Regranex 55 lipid parameters 55 liver toxicity 55 atherothrombosis 55 thrombotic events 55 NATRECOR R 54 GRNCM1 54 haematological 54 lipid lowering agents 54 OsmoPrep 54 TACI Ig 54 tumor lysis syndrome 54 neurologic symptoms 54 Quetiapine 54 Valproate 54 ADEs 54 RH1 54 placebo controlled clinical 54 ezetimibe simvastatin 54 lumiracoxib 54 juvenile idiopathic arthritis 54 Entereg R 54 intracerebral hemorrhage 54 acetaminophen poisoning

Back to home page